DGB-01 Effects on Endurance Exercise
| Status: | Recruiting |
|---|---|
| Conditions: | Other Indications |
| Therapuetic Areas: | Other |
| Healthy: | No |
| Age Range: | 18 - 60 |
| Updated: | 10/19/2013 |
| Start Date: | February 2012 |
| Contact: | William Black, MD |
| Email: | wsblac0@uky.edu |
| Phone: | (859) 218-3276 |
The purpose of this research is to evaluate the effects of DGB-01 on performance of a 40‐km
time trial in trained male cyclists. The investigators believe that DGB-01 will improve
performance on the time trial as measured by a reduction in the amount of time required to
complete the distance, using a computerized cycle ergometer.
Inclusion Criteria:
- Healthy males who are trained cyclists with a maximal oxygen uptake relative to body
weight equal to or greater than 45 ml O2/kg/min.
- Subjects must be in the competitive phase of their annual training cycle.
- Between ages of 18-60
- Availability- commitment of the subject/expected participation in the study for 97
days.
Exclusion Criteria:
- Specific allergy to milk proteins (this is different from lactose intolerance)
- Use of immunosuppressive medication in the case of organ transplants
- Planned surgeries.
- Kidney disorders
- Use of antihypertensive medications
- Cardiovascular disease
- Abnormal BUN, creatinine, hemoglobin, or hematocrit
- Body weight greater than 285 pounds
- A protein-restricted diet
- Subjects currently using dry whey protein supplements, N-acetylcysteine, or
alpha-lipoic acid supplements. The wash-out period is 1 month for any of these
supplements.
- All medications that can interfere with muscle mass such as corticosteroids (e.g.
prednisone), testosterone replacement or anabolic drugs such as Megace
We found this trial at
1
site
Click here to add this to my saved trials
